Patrick Gallagher
Corporate Officer/Principal presso SENSEI BIOTHERAPEUTICS, INC.
Patrimonio netto: 34 130 $ in data 30/04/2024
Posizioni attive di Patrick Gallagher
Società | Posizione | Inizio | Fine |
---|---|---|---|
SENSEI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2022 | - |
Storia della carriera di Patrick Gallagher
Precedenti posizioni note di Patrick Gallagher
Società | Posizione | Inizio | Fine |
---|---|---|---|
Binney Street Partners, LLC | Corporate Officer/Principal | 01/10/2020 | 01/06/2022 |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Corporate Officer/Principal | 01/03/2018 | 01/01/2020 |
RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/01/2016 | 01/01/2018 |
PFIZER, INC. | Vendite & Marketing | - | - |
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Celexion LLC
Celexion LLC Pharmaceuticals: MajorHealth Technology Celexion LLC develops platform technologies and products in the pharmaceutical, industrial, agricultural and life science research sectors. The company was founded by Brian Baynes in 2009 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 06/09/2011 | - |
Formazione di Patrick Gallagher
Boston University | Graduate Degree |
Ohio Wesleyan University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Israele | 2 |
Posizioni
Corporate Officer/Principal | 6 |
Sales & Marketing | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
PFIZER, INC. | Health Technology |
SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Celexion LLC
Celexion LLC Pharmaceuticals: MajorHealth Technology Celexion LLC develops platform technologies and products in the pharmaceutical, industrial, agricultural and life science research sectors. The company was founded by Brian Baynes in 2009 and is headquartered in Cambridge, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Binney Street Partners, LLC | |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Finance |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Patrick Gallagher
- Esperienza